MedTrace Logo

MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction

NCT00859300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1011

Last updated 2016-03-16

No results posted yet for this study

Summary

We propose a comparative case-control study on the 2 following groups of patients:

* Cases: 500 patients with ventricular fibrillation at the acute phase of myocardial infarct,
* Controls: 500 patients without ventricular fibrillation at the acute phase of myocardial infarct.

The primary endpoint in this study is the correlation phenotype/genotype of sudden death at the acute phase of myocardial infarct.

The first phase of the study, including patients' recruitment, clinical and biological data collection, will last 82 months. The second phase will concern the genotype/phenotype analysis and the identification of polymorphisms associated with a sudden death risk after a myocardial infarction.

This study will allow a better knowledge of the mechanisms of sudden death and the identification of new risk markers.

Conditions

Interventions

GENETIC

Blood sample

Blood sample Determination of genetic background

GENETIC

Blood sample

Blood sample Determination of genetic background

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • CHEVALIER Philippe, MD · Hospices Civils de Lyon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00859300 on ClinicalTrials.gov